What have we learned from brucellosis in the mouse model?

What have we learned from brucellosis in the mouse model?

<p>Abstract</p> <p>Brucellosis is a zoonosis caused by Brucella species. Brucellosis research in natural hosts is often precluded by practical, economical and ethical reasons and mice are widely used. However, mice are not natural Brucella hosts and the course of murine brucellosis...

Full description

Bibliographic Details
Main Authors:	Grilló María-Jesús, Blasco José, Gorvel Jean, Moriyón Ignacio, Moreno Edgardo
Format:	Article
Language:	English
Published:	BMC 2012-04-01
Series:	Veterinary Research
Online Access:	http://www.veterinaryresearch.org/content/43/1/29

Similar Items

Facing the Human and Animal Brucellosis Conundrums: The Forgotten Lessons
by: Edgardo Moreno, et al.
Published: (2022-04-01)

Brucellosis and One Health: Inherited and Future Challenges
by: Ignacio Moriyón, et al.
Published: (2023-08-01)

Pathogenicity and Its Implications in Taxonomy: The <i>Brucella</i> and <i>Ochrobactrum</i> Case
by: Edgardo Moreno, et al.
Published: (2022-03-01)

Brucellosis vaccines: assessment of Brucella melitensis lipopolysaccharide rough mutants defective in core and O-polysaccharide synthesis and export.
by: David González, et al.
Published: (2008-01-01)

What have we learned?
by: Peter Rodgers, et al.
Published: (2021-12-01)

Chernobyl and Fukushima nuclear accidents: What have we learned and what have we done?
by: Đurović Branka, et al.
Published: (2016-01-01)

GOAL: What Have We Learned?
by: Leek Timothy
Published: (2005-09-01)

What have we learned from the pandemic?
by: Iêda Maria Barbosa Aleluia
Published: (2021-03-01)

Retrospective and prospective perspectives on zoonotic brucellosis
by: Edgardo eMoreno, et al.
Published: (2014-05-01)

Immunosuppressive Mechanisms in Brucellosis in Light of Chronic Bacterial Diseases
by: Joaquin Miguel Pellegrini, et al.
Published: (2022-06-01)

Immune Response to Human Metapneumovirus Infection: What We Have Learned from the Mouse Model
by: Nagarjuna R. Cheemarla, et al.
Published: (2015-09-01)

Immunomodulatory properties of Brucella melitensis lipopolysaccharide determinants on mouse dendritic cells in vitro and in vivo
by: Yun Zhao, et al.
Published: (2018-12-01)

Cardiovascular Imaging: What Have We Learned From Animal Models?
by: Arnoldo eSantos, et al.
Published: (2015-10-01)

The pilocarpine model of epilepsy: what have we learned?
by: Fulvio A. Scorza, et al.
Published: (2009-09-01)

A review of three decades of use of the cattle brucellosis rough vaccine Brucella abortus RB51: myths and facts
by: J. M. Blasco, et al.
Published: (2023-10-01)

The Gonadotropin-Inhibitory Hormone: What We Know and What We Still Have to Learn From Fish
by: María P. Di Yorio, et al.
Published: (2019-02-01)

What have we learned? : ten years on /
by: Ashkanasy, Neal M., 1945-, et al.
Published: (2011)

Orthopaedic infections: what have we learned?
by: Christopher Lee, MD, et al.
Published: (2023-05-01)

Development Economics: What Have We Learned?
by: Jagdish N. Bhagwati
Published: (1984-01-01)

Phage Therapy: What Have We Learned?
by: Andrzej Górski, et al.
Published: (2018-05-01)

COVID-19: what have we learned?
by: Yeh-Li Ho, et al.
Published: (2020-06-01)

COVID-19 pandemic. What have we learned?
by: Cristina Calvo, et al.
Published: (2021-11-01)

Tegumentary leishmaniasis in the State of Amazonas: what have we learned and what do we need?
by: Jorge Augusto de Oliveira Guerra, et al.
Published: (2015-06-01)

Lipoabdominoplasty: What We Have Implemented and What We Have Modified over 26 Years
by: Lázaro Cárdenas-Camarena, MD, et al.
Published: (2023-02-01)

What we have learned from the Myriad trials.
by: Hendrix, S, et al.
Published: (2009)

Development and democracy : what have we learned and how? /
by: Hyden, Goran, et al.
Published: (2002)

What Have We Not Learned from the Convergence Debate?
by: Leone Leonida
Published: (2023-04-01)

The COVID-19 challenge. What have we learned?
by: Adrian Ceccato, et al.
Published: (2022-11-01)

Fifty Years of the Hypotelminorheic: What Have We Learned?
by: Tanja Pipan, et al.
Published: (2012-12-01)

What we have learned from the Rigopiano tragedy
by: Antonella Pescini, et al.
Published: (2019-12-01)

Lymphopenia in Esophageal Cancer: What Have We Learned?
by: Jia-Lin Wang, et al.
Published: (2021-03-01)

The infrared Galactic disk: What have we learned?
by: Churchwell E.
Published: (2012-02-01)

The economics of agricultural development: what have we learned?
by: Roumasset James
Published: (2006-07-01)

COVID-19 pandemic – What have we learned?
by: Manjunath Premanath
Published: (2021-01-01)

Five decades of Fontan palliation: What have we learned? What should we expect?
by: Adil Hassan, et al.
Published: (2023-10-01)

Nonalcoholic fatty liver disease: What do we know and what will we have to learn?
by: N I Volkova, et al.
Published: (2017-02-01)

Implementation of HPV Tests in Latin America: What We Learned; What Should We Have Learned, and What Can We Do Better?
by: Luani Rezende Godoy, et al.
Published: (2022-05-01)

III-V CMOS: What have we learned from HEMTs?
by: del Alamo, Jesus A., et al.
Published: (2012)

What we have accomplished and what we can achieve
by: A. Morais
Published: (2014-03-01)

Personalizing antiplatelet therapies: What have we learned from recent trials?
by: Sébastien Landry, et al.
Published: (2018-02-01)